Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomized, double-blind, parallel group, placebo controlled, multi center dose ranging study of solifenacin succinate (3 mg, 6 mg and 9 mg) in combination with tamsulosin OCAS 0.4 mg compared with solifenacin succinate monotherapy (3 mg, 6 mg and 9 mg) and tamsulosin OCAS 0.4 mg monotherapy in males with lower urinary tract symptoms https://www.kusajili.fr:443/Trial/JL2Dey2jh0mXAVpkqt7_JQ%24a-randomized-double-blind-parallel-group-placebo-controlled-multi-center-dose-ranging-study-of-solifenacin-succinate-3-mg-6-mg-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message